Annual Report 2018
Consolidated Annual Report 2018
Biocon Annual Report 2018 captures Biocon’s journey of endurance across the arduous and long path of innovation-led biotechnology research, which has given the Company the edge in bringing to patients life-saving biopharmaceuticals for chronic therapies like Diabetes, Oncology and Immunology that are affordable and thus accessible.
BIOCON’S JOURNEY OF ENDURANCE: Download
FINANCIAL REPORT: Download